PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells

Biochemical and Biophysical Research Communications

Volumn 306, Issue 4, 2003, Pages 887-897

  Eibl, Guido ^a   Bruemmer, Dennis ^a   Okada, Yuji ^a   Duffy, John P ^a   Law, Ronald E ^a   Reber, Howard A ^a   Hines, Oscar J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autocrine loop; COX 2; EP receptor; Pancreatic cancer; Prostaglandin; VEGF

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 8 BROMO CYCLIC AMP; ARACHIDONIC ACID; CYCLIC AMP; CYCLOOXYGENASE 2; NIMESULIDE; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

AGOUTI PACA;

EID: 0037757694     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01079-9     Document Type: Article

References (47)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002, CA. Cancer J. Clin. 52:2002;23-47.
2. Spencer A.G., Woods J.W., Arakawa T., Singer I.I., Smith W.L. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J. Biol. Chem. 273:1998;9886-9893.
3. Smith W.L., Marnett L.J., DeWitt D.L. Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther. 49:1991;153-179.
4. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38:1998;97-120.
5. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta. 1259:1995;109-119.
6. Sheng H., Shao J., Washington M.K., DuBois R.N. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276:2001;18075-18081.
7. Liu X.H., Kirschenbaum A., Lu M., Yao S., Klausner A., Preston C., Holland J.F., Levine A.C. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem. Biophys. Res. Commun. 290:2002;249-255.
8. Dohadwala M., Batra R.K., Luo J., Lin Y., Krysan K., Pold M., Sharma S., Dubinett S.M. Autocrine/paracine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J. Biol. Chem. 277:2002;50828-50833.
9. Nithipatikom K., Isbell M.A., Lindholm P.F., Kajdacsy-Balla A., Kaul S., Campell W.B. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin. Exp. Metastasis. 19:2002;593-601.
10. Bamba H., Ota S., Kato A., Kawamoto C., Fujiwara K. Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. Biochem. Biophys. Res. Commun. 273:2000;485-491.
11. Bamba H., Ota S., Kato A., Kawamoto C., Matsuzaki F. Effect of prostaglandin E1 on vascular endothelial growth factor production by human macrophages and colon cancer cells. J. Exp. Clin. Cancer Res. 19:2000;219-223.
12. Casibang M., Purdom S., Jakowlew S., Neckers L., Zia F., Ben Av P., Hla T., You L., Jablons D.M., Moody T.W. Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells. Lung Cancer. 31:2001;203-212.
13. Harada S., Nagy J.A., Sullivan K.A., Thomas K.A., Endo N., Rodan G.A., Rodan S.B. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J. Clin. Invest. 93:1994;2490-2496.
14. Pai R., Szabo I.L., Soreghan B.A., Atay S., Kawanaka H., Tarnawski A.S. PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochem. Biophys. Res. Commun. 286:2001;923-928.
15. Wolff H., Saukkonen K., Anttila S., Karjalainen A., Vainio H., Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 58:1998;4997-5001.
16. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1994;1183-1188.
17. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789.
18. Gupta S., Srivastava M., Ahmad N., Bostwick D.G., Mukhtar H. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate. 42:2000;73-78.
19. Hwang D., Scollard D., Byrne J., Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Natl. Cancer Inst. 90:1998;455-460.
20. Tucker O.N., Dannenberg A.J., Yang E.K., Zhang F., Teng L., Daly J.M., Soslow R.A., Masferrer J.L., Woerner B.M., Koki A.T., Fahey III T.J. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 59:1999;987-990.
21. Williams C.S., Luongo C., Radhika A., Zhang T., Lamps L.W., Nanney L.B., Beauchamp R.D., DuBois R.N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology. 111:1996;1134-1140.
22. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., Taketo M.M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809.
23. DuBois R.N., Shao J., Tsujii M., Sheng H., Beauchamp R.D. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res. 56:1996;733-737.
24. Lin M.T., Lee R.C., Yang P.C., Ho F.M., Kuo M.L. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 276:2001;48997-49002.
25. Tsujii M., Kawano S., DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA. 94:1997;3336-3340.
26. Costa C., Soares R., Reis-Filho J.S., Leitao D., Amendoeira I., Schmitt F.C. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J. Clin. Pathol. 55:2002;429-434.
27. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:1998;705-716.
28. Kokawa A., Kondo H., Gotoda T., Ono H., Saito D., Nakadaira S., Kosuge T., Yoshida S. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer. 91:2001;333-338.
29. Koshiba T., Hosotani R., Miyamoto Y., Wada M., Lee J.U., Fujimoto K., Tsuji S., Nakajima S., Doi R., Imamura M. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors. Int. J. Pancreatol. 26:1999;69-76.
30. Merati K., said Siadaty M., Andea A., Sarkar F., Ben-Josef E., Mohammad R., Philip P., Shields A.F., Vaitkevicius V., Grignon D.J., Adsay N.V. Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters. Am. J. Clin. Oncol. 24:2001;447-452.
31. Molina M.A., Sitja-Arnau M., Lemoine M.G., Frazier M.L., Sinicrope F.A. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res. 59:1999;4356-4362.
32. Niijima M., Yamaguchi T., Ishihara T., Hara T., Kato K., Kondo F., Saisho H. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas. Cancer. 94:2002;1565-1573.
33. Yip-Schneider M.T., Barnard D.S., Billings S.D., Cheng L., Heilman D.K., Lin A., Marshall S.J., Crowell P.L., Marshall M.S., Sweeney C.J. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis. 21:2000;139-146.
34. Eibl G., Reber H.A., Wente M.N., Hines O.J. The selective COX-2 inhibitor nimesulide induces apoptosis in pancreatic cancer cells independent of COX-2. Pancreas. 26:2003;33-41.
35. Tseng W.W., Deganutti A., Chen M.N., Saxton R.E., Liu C.D. Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer. J. Gastrointest. Surg. 6:2002;838-843.
36. Yip-Schneider M.T., Sweeney C.J., Jung S.H., Crowell P.L., Marshall M.S. Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J. Pharmacol. Exp. Ther. 298:2001;976-985.
37. Ding X.Z., Tong W.G., Adrian T.E. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res. 20:2000;2625-2631.
38. Reddy S.T., Herschman H.R. Transcellular prostaglandin production following mast cell activation is mediated by proximal secretory phospholipase A2 and distal prostaglandin synthase 1. J. Biol. Chem. 271:1996;186-191.
39. Reddy S.T., Herschman H.R. Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells. J. Biol. Chem. 272:1997;3231-3237.
40. Kashiwagi M., Friess H., Uhl W., Berberat P., Abou-Shady M., Martignoni M., Anghelacopoulos S.E., Zimmermann A., Buchler M.W. Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis. Gut. 45:1999;605-612.
41. Aoki T., Nagakawa Y., Tsuchida A., Kasuya K., Kitamura K., Inoue K., Ozawa T., Koyanagi Y., Itoi T. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors. Oncol. Rep. 9:2002;761-765.
42. Hotz H.G., Gill P.S., Masood R., Hotz B., Buhr H.J., Foitzik T., Hines O.J., Reber H.A. Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer. J. Gastrointest. Surg. 6:2002;159-166.
43. Buechler P., Reber H.A., Buechler M.W., Friess H., Hines O.J. VEGF-RII influences the prognosis of pancreatic cancer. Ann. Surg. 236:2002;738-749.
44. Hoper M.M., Voelkel N.F., Bates T.O., Allard J.D., Horan M., Shepherd D., Tuder R.M. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am. J. Respir. Cell Mol. Biol. 17:1997;748-756.
45. Sonoshita M., Takaku K., Sasaki N., Sugimoto Y., Ushikubi F., Narumiya S., Oshima M., Taketo M.M. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(delta 716) knockout mice. Nat. Med. 7:2001;1048-1051.
46. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 3:2000;389-395.
47. Chu J., Lloyd F.L., Trifan O.C., Knapp B., Rizzo M.T. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer. Mol. Cancer Ther. 2:2003;1-7.